 |
市場調査レポート
商品コード
968314
バイオニック・アイの世界市場：タイプ別（外部眼、移植眼）、技術別（電子、機械）、エンドユース別（病院、眼科クリニック、その他）、地域別の市場規模調査と展望（2020年～2027年）Global Bionic Eye Market Size study, by Type (External Eye, Implanted Eye), by Technology (Electronic, Mechanical), by End-Use (Hospitals, Ophthalmic Clinics, Others) and Regional Forecasts 2020-2027 |
||||||
| バイオニック・アイの世界市場：タイプ別（外部眼、移植眼）、技術別（電子、機械）、エンドユース別（病院、眼科クリニック、その他）、地域別の市場規模調査と展望（2020年～2027年） |
|
出版日: 2020年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
|
バイオニック・アイの市場規模は2019年に約1億8,350万米ドルとなり、2020年～2027年の予測期間中に12.7％を超える健全な成長率で成長すると予想されています。人工視覚装置とも呼ばれるバイオニック・アイは、部分的または完全な失明をしている患者の視覚機能を回復するために使用される、実験的な視覚装置です。個人の失明を治癒するために、多くの装置および手術が開発されており、通常は人工内耳またはバイオニック・イヤー装置をモデルにしています。バイオニック・アイは通常、脳に視覚を与えることができる人工眼と見なされ、多くの場合、人の視覚能力の向上に役立ち、その結果、世界的により高い市場成長がもたらされます。さらに、高齢者人口の増加による眼疾患の有病率の上昇、公的および民間組織による資金調達の増加、および製品革新に焦点を当てた集中的な研究開発（R＆D）は、予測期間中の市場の印象的なCAGRの原因となるいくつかの要因です。
世界保健機関によると、2019年10月に世界中で22億人近くが視力障害または失明の影響を受け、そのうち少なくとも10億人が予防可能または診断されていない状態にありました。同様に、国際失明予防庁によると、2018年には2,100万人以上のベトナム人が眼科医療サービスを必要としており、そのうち300万人以上が、視力に問題を抱えたベトナム人学生です。したがって、視力関連の合併症の急増は、治療または矯正装置の採用を促進する可能性があり、これは世界的なバイオニック・アイの需要の増加につながっています。ただし、バイオニック・アイの高コストと高研究開発コストは、2020年～2027年の予測期間にわたって市場の成長を制限する主な要因です。
当レポートではバイオニック・アイの世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、タイプ・技術・エンドユース・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。
Global Bionic Eye Market is valued at approximately USD 183.5 million in 2019 and is anticipated to grow with a healthy growth rate of more than 12.7% over the forecast period 2020-2027. Bionic eye, also referred to as visual prosthesis, is an experimental visual device used to restore the visual function of the patient experiencing partial or complete blindness. Many devices and surgeries have been developed, typically modeled on the cochlear implant or bionic ear device, so as to heal the blindness of the individuals. Bionic eye is usually considered as artificial eye which can deliver visual sensation to the brain and often helps the people to improve the vision abilities, which is resulting in the higher market growth across the globe. Furthermore, the rise in prevalence of ophthalmic diseases due to growing geriatric population, increasing funding by public and private organizations, and intensive research and development (R&D) focused on product innovation are the few factors responsible for the impressive CAGR of the market during the forecast period. According to the World Health Organization, nearly 2.2 billion people were affected with vision impairment or blindness in October 2019, of which at least 1 billion people had preventable or unaddressed conditions around the world. Similarly, as per the International Agency for the Prevention of Blindness, in 2018, more than 21 million of Vietnamese required eye care services, Out of which over 3 million Vietnamese students are having eyesight problems. Thus, surge in vision-related complications may promote the adoption of the therapeutic or corrective devices, which has led to a boost in the demand for bionic eye all over the world. However, the high cost of bionic eye and the high research and development cost are the prime factors limiting the market growth over the forecast period of 2020-2027.
The regional analysis of the global Bionic Eye market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising awareness concerning vision-related problem, intensive research activities, and the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence eye-related or ophthalmic disorder such as myopia and presbyopia coupled with growing geriatric population across developing countries, such as China and India, would create lucrative growth prospects for the Bionic Eye market across the Asia-Pacific region.
Major market player included in this report are:
Second Sight Medical Products LLC
Nidek Co. Ltd.
Nano Retina Ltd.
MetaModal LLC
Biomedical Technologies
Bionic Vision Technologies
NeoStrata
Monash Vision Group
Pixium Vision
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
External Eye
Implanted Eye
By Technology:
Electronic
Mechanical
By End-Use:
Hospitals
Ophthalmic Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2017, 2018
Base year - 2019
Forecast period - 2020 to 2027
Target Audience of the Global Bionic Eye Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
比較リスト
